Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maryana A. Lysenko
Observed names:
M.A. Lysenko,
Maryana Lysenko,
Mar’yana A. Lysenko,
Mar’yana Lysenko
Institutions:
Pirogov Russian National Research Medical University,
Moscow Clinical Scientific Center,
Moscow Clinical Science and Research Center 52
Observed institutions:
Sechenov University,
Pirogov Russian National Research Medical University,
Endocrinology Research Center,
Moscow Clinical Scientific Center,
City Clinical Hospital,
Moscow Clinical Science and Research Center 52
show all 6
ORCID:
0000-0001-6010-7975
Observed ORCID:
0000-0001-6010-7975
OpenAlex ID:
A5110714966
Pheochromocytoma Surgery: Epidemiologic Peculiarities in Children
2004
·
Dmitry G. Beltsevich
, Nikolay S. Kuznetsov
, et al.
·
World Journal of Surgery
·
62
Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia
2020
·
Daria S. Fomina
, Mar’yana A. Lysenko
, et al.
·
Pathogens and Immunity
·
28
PDF
Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
2022
·
E.A. Bryushkova
, V.D. Skatova
, et al.
·
PLoS ONE
·
16
Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital
2022
·
Marina Shestakova
, Irina Kononenko
, et al.
·
PLoS ONE
·
10
PDF
Chronic inducible urticaria – having more than one is common and clinically relevant
2025
·
Marina Lebedkina
, Elena Kovalkova
, et al.
·
Frontiers in Immunology
·
9
PDF
Treatment of atopic dermatitis with upadacitinib: adcare single center experience
2024
·
Daria S. Fomina
, Olga A. Mukhina
, et al.
·
Frontiers in Medicine
·
9
PDF
Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
2022
·
Anna Lebedeva
, Ivan Molodtsov
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids
2023
·
Ekaterina A. Nikitina
, Daria S. Fomina
, et al.
·
Frontiers in Medicine
·
7
PDF
Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
2023
·
Daria S. Fomina
, Marina S. Lebedkina
, et al.
·
Frontiers in Immunology
·
5
PDF
Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19
2021
·
Tatyana S. Kruglova
, Darya S. Fomina
, et al.
·
Terapevticheskii arkhiv
·
5
PDF
Predictive value of a severity-of-illness score for toxic epidermal necrolysis (SCORTEN) factors for in-hospital mortality in Stevens–Johnson syndrome/toxic epidermal necrolysis
2026
·
Ekaterina Nikitina
, Alexander Dushkin
, et al.
·
Frontiers in Medicine
·
4
PDF
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case
2022
·
Olgo A. Mukhina
, Daria S. Fomina
, et al.
·
Human Vaccines & Immunotherapeutics
·
4
PDF
Pb2588: Predictive Model of In-hospital Case Fatality in Patients With Diffuse Large B-cell Lymphoma Developing Coronavirus Infection
2023
·
Yuri Polyakov
, Elena Baryakh
, et al.
·
HemaSphere
Features of the Development and Application of Diagnostic ELISA Systems for the Detection of Antibodies to the SARS-CoV-2 Coronavirus in Clinical Practice
2021
·
Elena I. Zagoruyko
, Dmitriy A. Kudlay
, et al.
·
Medical academic journal
PDF
Show more works
View as search
Works count:
14
Citation count:
167
H-index:
7
I10-index:
4
Year
Topic
Type